Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Antibiotic Prophylaxis for Bladder Botox 06/23/2020 INTERVENTIONAL not-comparable 2,300.75 0 INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study 06/24/2020 INTERVENTIONAL not-comparable 2,299.75 0 Open Nipple Sparing Mastectomy (NSM) 06/25/2020 OBSERVATIONAL not-comparable 2,298.75 0 Bern Birth Cohort / Trajectory of Microbiota Maturation in Healthy Bern Infants - a Network Approach 06/25/2020 OBSERVATIONAL not-comparable 2,298.75 0 Dilapan-S®: A Multicenter US E-registry 06/30/2020 OBSERVATIONAL not-comparable 2,293.75 0 Early Gestational Diabetes Mellitus 06/30/2020 INTERVENTIONAL not-comparable 2,293.75 0 Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer 07/01/2020 INTERVENTIONAL not-comparable 2,292.75 0 Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer 07/01/2020 INTERVENTIONAL not-comparable 2,292.75 0 Evaluation of the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment. 07/07/2020 INTERVENTIONAL not-comparable 2,286.75 0 Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer 07/07/2020 INTERVENTIONAL not-comparable 2,286.75 0 Tomosynthesis as Primary Test for Breast Cancer Screening 07/08/2020 INTERVENTIONAL not-comparable 2,285.75 0 The EMBRACE Study The EMBRACE Study 07/13/2020 OBSERVATIONAL not-comparable 2,280.75 0 Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone 07/13/2020 INTERVENTIONAL not-comparable 2,280.75 0 Minimum Effective Duration of Intrauterine Balloon Tamponade for the Management of Postpartum Hemorrhage 07/13/2020 INTERVENTIONAL not-comparable 2,280.75 0 Diet Modification in pAtients With Luminal Early Breast Cancer Candidate for Primary Surgery 07/14/2020 INTERVENTIONAL not-comparable 2,279.75 0 Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer 07/14/2020 INTERVENTIONAL not-comparable 2,279.75 0 PREPARE: Patient Centered Perioperative Experience 07/15/2020 INTERVENTIONAL not-comparable 2,278.75 0 A Prospective Study of a Mosaic Embryo Transfer 07/15/2020 INTERVENTIONAL not-comparable 2,278.75 0 HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART). 07/15/2020 INTERVENTIONAL not-comparable 2,278.75 0 Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer 07/16/2020 INTERVENTIONAL not-comparable 2,277.75 0 Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ) 07/16/2020 INTERVENTIONAL not-comparable 2,277.75 0 Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 Study 07/17/2020 OBSERVATIONAL not-comparable 2,276.75 0 Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy 07/20/2020 OBSERVATIONAL not-comparable 2,273.75 0 Affect of Duavive on Mood & Anxiety Symptoms 07/20/2020 INTERVENTIONAL not-comparable 2,273.75 0 PROJECT PREVENT: Metronidazole Antibiotic Per Vagina Before Hysterectomy: Is Additional Antibiotic Prophylaxis Beneficial? 07/20/2020 INTERVENTIONAL not-comparable 2,273.75 0 Transvaginal Mesh vs. Laparoscopic Colposacropexy- Study 07/21/2020 INTERVENTIONAL not-comparable 2,272.75 0 Aspirin and Preeclampsia 07/21/2020 INTERVENTIONAL not-comparable 2,272.75 0 Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions 07/21/2020 INTERVENTIONAL not-comparable 2,272.75 0 Clinical and Molecular Study of Endometriosis and Adenomyosis 07/22/2020 OBSERVATIONAL not-comparable 2,271.75 0 Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer 07/22/2020 INTERVENTIONAL not-comparable 2,271.75 0 RCT of CBD for Anxiety in Advanced Breast Cancer 07/22/2020 INTERVENTIONAL not-comparable 2,271.75 0 A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer 07/24/2020 INTERVENTIONAL not-comparable 2,269.75 0 Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer 07/24/2020 OBSERVATIONAL not-comparable 2,269.75 0 Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial 07/27/2020 INTERVENTIONAL not-comparable 2,266.75 0 A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer 07/27/2020 INTERVENTIONAL not-comparable 2,266.75 0 Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy 07/31/2020 INTERVENTIONAL not-comparable 2,262.75 0 A Study to Identify Breast Cancer (IDBC) 07/31/2020 OBSERVATIONAL not-comparable 2,262.75 0 CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer 08/03/2020 OBSERVATIONAL not-comparable 2,259.75 0 Poke and a Placebo 08/04/2020 INTERVENTIONAL not-comparable 2,258.75 0 Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery 08/04/2020 INTERVENTIONAL not-comparable 2,258.75 0 Peripartum Mental Health Cohort Study in Guangzhou 08/05/2020 OBSERVATIONAL not-comparable 2,257.75 0 Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria 08/06/2020 INTERVENTIONAL not-comparable 2,256.75 0 A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC 08/06/2020 INTERVENTIONAL not-comparable 2,256.75 0 European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III 08/07/2020 OBSERVATIONAL not-comparable 2,255.75 0 Real Time Molecular Analysis of Breast Cancer Receiving Neo-adjuvant Chemotherapy 08/07/2020 OBSERVATIONAL not-comparable 2,255.75 0 Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer 08/11/2020 INTERVENTIONAL not-comparable 2,251.75 0 Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer 08/12/2020 INTERVENTIONAL not-comparable 2,250.75 0 CONFIRM EXTENSION - Long-term Follow-up Study of Patients Treated with AGN1 LOEP 08/13/2020 INTERVENTIONAL not-comparable 2,249.75 0 Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal 08/13/2020 INTERVENTIONAL not-comparable 2,249.75 0 Mindfulness in Endometrial and Cervical Cancer 08/13/2020 INTERVENTIONAL not-comparable 2,249.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology